Patents/Inventors

Giles Albert Brown

CambridgeGB20 patents

19 Patents

US125527992026
Triazolone Compounds
NXERA PHARMA UK LIMITED
0 cites
US125288152026
5-amino-8-(4-pyridyl)-[1,2,4]triazolo[4,3-c]pyrimidin-3-one Compounds for Use Against Cancer
Nxera Pharma UK Limited
0 cites
US124921742025
Morpholine-3-carboxamide Derivatives as Prostaglandin E2 Receptor 4 (EP4) Agonists for the Treatment of Gastrointestinal and Pulmonary Diseases
Nxera Pharma UK Limited
0 cites
US124417772025
GLP-1 Receptor Antagonists
Nxera Pharma UK Limited
0 cites
US123446212025
CGRP Antagonist Compounds
Nxera Pharma UK Limited
0 cites
US123310292025
Orexin 1 Receptor Antagonists
Nxera Pharma UK Limited
0 cites
US122915122025
Oxime Compounds as Agonists of the Muscarinic M 1 And/or M 4 Receptor
Nxera Pharma UK Limited
0 cites
US122408252025
Oxexin 1 Receptor Antagonists
NXERA PHARMA UK LIMITED
0 cites
US122342272025
Pyrazole Derivatives as H4 Antagonist Compounds
NXERA PHARMA UK LIMITED
0 cites
US122275212025
CGRP Antagonist Compounds
Nxera Pharma UK Limited
0 cites
US122150992025
Quinolinone and Benzoxazine Derivatives as Muscarinic M 1 And/or M 4 Receptor Agonists
Nxera Pharma UK Limited
0 cites
US122028432025
Muscarinic Receptor Agonists
Nxera Pharma UK Limited
0 cites
US120544722024
1,2,4-triazine-4-amine Derivatives
Nxera Pharma UK Limited
0 cites
US120244992024
Muscarinic Agonists
Heptares Therapeutics Limited
0 cites
US119876482024
Cyclohexapeptides as Selective Somatostatin SST5 Receptor Agonists
Heptares Therapeutics Limited
0 cites
US119458012024
Bicyclic Aza Compounds as Muscarinic M 1 And/or M 4 Receptor Agonists
Allergan Pharmaceuticals International Limited
0 cites
US118344072023
Substituted Cyclohexanes as Muscarinic M1 Receptor And/or M4 Receptor Agonists
Heptares Therapeutics Limited
0 cites
US117938172023
Muscarinic M1 Receptor Agonists
Heptares Therapeutics Limited
0 cites
US117730902023
Pharmaceutical Compounds
Heptares Therapeutics Limited
0 cites